Clinical trial
Device Evaluation of Contak Renewal 2and Easytrak 2 - DECREASE-HF
NCT00158951 · Boston Scientific Corporation, Industry · Completed
Key facts
| NCT number | NCT00158951 |
|---|---|
| Title | Device Evaluation of Contak Renewal 2and Easytrak 2 - DECREASE-HF |
| Official title | Device Evaluation of CONTAK(R) RENEWAL 2/4/4HE and EASYTRAK(R) 2: Assessment of Safety and Effectiveness in Heart Failure (DECREASE-HF) |
| Lead sponsor | Boston Scientific Corporation, Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Congestive Heart Failure |
| Intervention type | Device |
| Interventions | CONTAK RENEWAL 2/4/4HE CRT-D, EASYTRAK 2 Lead |
| Enrollment | 360 |
| Start date | Mar 1, 2003 |
| Completion | Oct 1, 2004 |
| First posted | Sep 12, 2005 |
| Last update posted | Jun 25, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: